MedPage Today on MSN
FDA Signals Regulatory Flexibility With Accelerated Approval of Rare Disease Drug
Tividenofusp alfa is the first approved treatment for neurologic complications of Hunter s ...
AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session Across the COAST 1, COAST 2, and SHORE phase 3 studies, amlitelimab, dosed ...
Transdermal estradiol offers fewer hot flashes and lower fracture rates, but higher rates of gynecomastia, as it meets the ...
I had breast cancer in my left breast 14 years ago.
State-Funded Screening Initiative Highlights Growing Public Sector Support for Innovative Cancer Detection Tools GAITHERSBURG, Md., March 27, ...
MedPage Today on MSN
Active Surveillance for DCIS Moves Closer to Standard Option but 'Not Quite There'
Large randomized trial makes case for non-inferiority versus surgery; smaller study falls ...
For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control ...
Spring training is full of optimism, and these 30 players have their teams especially giddy as we inch toward the regular ...
Oral TYK2 inhibitor deucravacitinib receives FDA approval for active psoriatic arthritis based on significantly improved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results